MedTrace Logo

Pancreatic Cancer Screening for At-risk Individuals

NCT05006131 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1395

Last updated 2026-04-23

No results posted yet for this study

Summary

The investigators' goal is to conduct a prospective multicenter study to evaluate the yield and outcomes of screening of pancreas cancer in individuals who are at-risk for pancreatic cancer. We plan to use International Cancer of the Pancreas Screening (CAPS3) Consortium recommendations to standardize study population, screening methodology, and study outcomes.

Conditions

  • Pancreatic Cancer, Adult

Interventions

OTHER

Screening for pancreatic cancer

Screening for pancreatic cancer using EUS or MRI

Sponsors & Collaborators

  • Washington University School of Medicine

    collaborator OTHER

  • Zucker School of Medicine at Hofstra/Northwell

    collaborator UNKNOWN

  • Rush University Medical Center

    collaborator OTHER

  • Wake Forest University

    collaborator OTHER

  • University of Arkansas

    collaborator OTHER

  • Beth Israel Deaconess Medical Center

    lead OTHER

Principal Investigators

  • Mandeep Sawhney, MD,MS,FASGE · BIDMC-Harvard Medical School

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-10
Primary Completion
2032-12-31
Completion
2032-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006131 on ClinicalTrials.gov